Here we monitored intratumoral and splenic CD8 + or CD4 + T cells longitudinally in response to ICB treatment in immunologically “cold” breast tumors using [89Zr]Zr-DFO-CD8 or [89Zr]Zr-DFO-CD4 PET imaging. This evidence concerns the gene CD4 and breast neoplasm.